Skip to content

SOPHARMA

Active
Public limited companyfounded 200124 yrs activeJezus Eiklaan 2A, 3080 Tervuren, BelgiumKBO/BCE: BE 0476.391.546
Summary

SOPHARMA has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €167.3m and a net result of €14.3m. Equity is growing by ~22.6% per year across the filed fiscal years. Its solvency ranks better than 95% of 4272 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Risk analysisWatch ReportCompare
SOPHARMAActiveChecked score 68/100
Risk analysis ReportCompare

Overview

What they do
Retail sale of pharmaceutical products
NACE 47730Warehousing and support activities for transportation NACE 52310
#1 company by total assets in Tervuren, Wholesale and retail trade sector1 site
How big
€172.1mtotal assets 2025
Staff
1.5 FTE
Equity
€167.3m
Profit
€14.3m
Net result +1,381%: other schema
Financially healthy?
68 Healthy Checked score 2025
Bankruptcy chance 12 m
0.3%
Who decides
Holdings
2
Accounts 1 d early0 of 10 deeds read
Why 68- Higher-failure-rate sector+ Annual accounts: healthy financial profile+ Long track record+ Lower-risk legal formLatest accounts filed on timeShow the evidence

Checked score

Score 2025
68 / 100
Healthy
Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability29▼-42
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2,000,000 at 30 days acceptable
Liquidity ample (current ratio 14.29 against 4.95 in 2024; short-term debt: 1.5% and cash: 0.5% of total assets), and 2.8% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
97.2%
Return on assets
8.3%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 24 years 0 30 y
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
1 d early
2024
66 d early
2023
36 d early
2022
47 d early
2021
61 d late
2020
31 d late
2019
25 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 12 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 26 June (4 of the last 5 filed years within 34 days of that day).
Companies Code · seven months
Position in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · full…
  2. Liquidity triplescurrent ratio 14.29
  3. Equity above €100mEq €167.3m ▲213%

Key points

  • Positive: Result rose in 2025different schema filed ▲ 1,381% View
  • Positive: Company by total assets in Tervuren, Wholesale and…in the Checked rankings #1 View
  • Positive: 8 profitable years in a rowprofit 2025: €14.3m 8 years View
  • Positive: Always filed on timeaccounts within the deadline every year 4 years View

By topic

Financials

Fiscal year
2025
Total assets
€172.1m
Profit
€14.3m
Solvency
97.2%
Total assets▲ 217%
Net result
20182025
Go to Financials

Timeline

Events
17
Since
2017
Next accounts
by 31-07-2027
  1. 30-07-2026Annual accounts filed
  2. 31-12-2025Liquidity triples
  3. 31-12-2025Equity above €100m
Go to Timeline

Support & recognitions

Funding sources
1
Recognitions
2 registers
Flemish government
€4,000awarded · 2022 - 2023
FASFC
1authorised site
LEI
active894500ONI4OZJGH40A50
Go to Support & recognitions

Company details

Sites
1
Legal form
Public limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
20-12-2001
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure